fbpx Skip to main content

TUESDAY, Nov. 17, 2020 (HealthDay News) — Lack of insurance coverage for gender-affirming hormones is associated with a lower likelihood of hormone use and higher odds of use of nonprescription hormones among transgender adults, according to a study published in the November issue of the Annals of Family Medicine.

Daphna Stroumsa, M.D., from the University of Michigan in Ann Arbor, and colleagues used data from the U.S. Transgender Survey (August to September 2015) to evaluate associations between insurance coverage for gender-affirming hormones and patterns of hormone use.

The researchers found that among 12,037 transgender adults using hormones, 9.17 percent were using nonprescription hormones. More than one in five insured respondents (20.81 percent) reported that their claims were denied. Respondents who were uninsured (odds ratio, 2.64) or whose claims were denied (odds ratio, 2.53) were more likely to use nonprescription hormones. Hormone use was less likely among uninsured respondents (odds ratio, 0.37).

“Ensuring access to hormones can decrease the economic burden transgender people face, and is an important part of harm-reduction strategies,” the authors write.

Abstract/Full Text

You May Also Like::  ACA's Reach Surges With 200,000 New Signups, More States Involved

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More